CBD has relaxing, anti-stress and analgesic effects without causing euphoria. It can relieve pain, reduce inflammation, improve sleep and help with certain pathologies such as epilepsy or neurological disorders. However, it can cause side effects such as drowsiness or dizziness, depending on the dose consumed.

Driving after consuming CBD is not recommended, although CBD is legal in France with a THC level of less than 0.3%. CBD can cause side effects such as drowsiness or decreased concentration, impairing the ability to drive. In addition, in the event of a road check, the detection of traces of THC, even tiny ones, can result in severe penalties (fine, license withdrawal, imprisonment).

CBD is widely used for its relaxing effects, helping to reduce stress, anxiety and improve sleep. It is also prized for relieving chronic pain and helping oncology patients better tolerate chemotherapy. Non-psychoactive, it offers a natural alternative for well-being.

Cannabidiol, or CBD, is a naturally occurring active compound in cannabis, also known as hemp. Unlike THC, it does not have a psychoactive effect, meaning it does not cause euphoria. CBD is present in all parts of the plant and is used for its potential wellness benefits, including reducing stress, anxiety, and relieving some pain.

No, cannabidiol (CBD) is not considered a narcotic or a psychotropic drug in France, because it does not cause psychotropic effects or addiction. Health Insurance describes it as a natural substance of cannabis (or hemp), authorized in its non-medical form, because it does not present a risk of euphoria or dependence.